Get it on Google Play

FDA accepts PolyPid's D-PLEX100 NDA with priority review

July 29, 2026 8:30 AM EDT Send to a Friend
PolyPid Ltd. (NASDAQ: PYPD) announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login